Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

Cited by (462)

Items 101–200 of 462

1. Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
   Marina Mattar, Florence Umutoni, Marwa A. Hassan, M. Wambui Wamburu, Reagan Turner, James S. Patton, Xin Chen, Wei Lei · 2024 · Life
2. Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study
   Ramin Safakish, Gordon D. Ko, Vahid Salimpour, Bryan Hendin, Imrat Sohanpal, Gena Loheswaran, Sun Young Yoon · 2020 · Pain Medicine
3. Use of Cannabis and Cannabinoids for Treatment of Cancer
   Viktoriia Cherkasova, Bo Wang, Marta Gerasymchuk, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk · 2022 · Cancers
4. The Prevalence and Significance of Cannabis Use in Patients Prescribed Chronic Opioid Therapy: A Review of the Extant Literature
   Gary M. Reisfield, Ajay D. Wasan, Robert N. Jamison · 2009 · Pain Medicine
5. Effects of cannabinoids and their receptors on viral infections
   Alireza Tahamtan, Masoumeh Tavakoli‐Yaraki, Tomasz P. Rygiel, Talat Mokhtari‐Azad, Vahid Salimi · 2015 · Journal of Medical Virology
6. Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
   Amber L. Milligan, Thomas A. Szabo-Pardi, Michael D. Burton · 2019 · Journal of Dual Diagnosis
7. The intersection between cannabis and cancer in the United States
   Daniel W. Bowles, Cindy L. O’Bryant, D. Ross Camidge, Antonio Jimeno · 2011 · Critical Reviews in Oncology/Hematology
8. Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
   Gregory T. Carter, Mary E. Abood, Sunil Kumar Aggarwal, Michael D. Weiss · 2010 · American Journal of Hospice and Palliative Medicine®
9. Frequency of Cannabis Use and Medical Cannabis Use Among Persons Living With HIV in the United States: Findings From a Nationally Representative Sample
   Lauren R. Pacek, Sheri L. Towe, Andréa L. Hobkirk, Denis Nash, Renée D. Goodwin · 2018 · AIDS Education and Prevention
10. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
    Karma Rabgay, Neti Waranuch, Nathorn Chaiyakunapruk, Ratree Sawangjit, Kornkanok Ingkaninan, Piyameth Dilokthornsakul · 2019 · Journal of the American Pharmacists Association
11. Cannabinoids and inflammation
    Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2019 · AIDS
12. Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results
    Aggarwal, Sunil K. · 2013 · The Clinical Journal of Pain
13. Patterns and Correlates of Cannabis Use among Individuals with HIV/AIDS in Maritime Canada
    Gregory E. Harris, Lise Dupuis, Gerald J. Mugford, L. D. Johnston, David A. Haase, Ginny Page, Heather Haldane, Nicholas M. Harris, William K. Midodzi, Gordon Dow · 2014 · Canadian Journal of Infectious Diseases and Medical Microbiology
14. Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey
    Des Crowley, Claire Collins, Íde Delargy, Eamon J. Laird, Marie Claire Van Hout · 2017 · Harm Reduction Journal
15. Role of Cannabinoids in Pain Management
    Ethan B. Russo, Andrea G. Hohmann · 2012 · Springer eBooks
16. Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis
    Bradley Sainsbury, Jared Bloxham, Masoumeh Hassan Pour, Mariela Padilla, Reyes Enciso · 2021 · Journal of Dental Anesthesia and Pain Medicine
17. Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal
    Jarkko Kalliomäki, Märta Segerdahl, Lynn Roy Webster, Annika Reimfelt, Karin Huizar, Peter Annas, Rolf Karlsten, Hans Quiding · 2013 · Scandinavian Journal of Pain
18. Evaluation of the analgesic efficacy and psychoactive effects of AZD 1940, a novel peripherally acting cannabinoid agonist, in human capsaicin‐induced pain and hyperalgesia
    Jarkko Kalliomäki, Peter Annas, Karin Huizar, Cyril P. Clarke, Annika Zettergren, Rolf Karlsten, Märta Segerdahl · 2013 · Clinical and Experimental Pharmacology and Physiology
19. HIV neuropathy
    Michelle C. Kaku, David M. Simpson · 2014 · Current Opinion in HIV and AIDS
20. Examining the roles of cannabinoids in pain and other therapeutic indications: a review
    Dana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, Emma E. Frost, Andrew J. Gomori, Mike Namaka · 2009 · Expert Opinion on Pharmacotherapy
21. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain
    Arunachalam Muthuraman, Nirmal Singh · 2012 · Journal of Ethnopharmacology
22. NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
    Stephen Brown, David M. Simpson, Graeme J Moyle, Bruce James Brew, Giovanni Schifitto, Nick Larbalestier, Chloe M. Orkin, Martin Fisher, Geertrui F. Vanhove, Jeffrey K. Tobias · 2013 · AIDS Research and Therapy
23. An Overview of Pharmacologic Management of Chronic Pain
    Benjamin R. Beal, Mark S. Wallace · 2015 · Medical Clinics of North America
24. The Association Between Marijuana Use and HIV Continuum of Care Outcomes: a Systematic Review
    LaTrice Montgomery, Kara Simone Bagot, Robert Brown, Angela M. Haeny · 2019 · Current HIV/AIDS Reports
25. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
    Shannon Inglet, Bradly Winter, Sarah E. Yost, Sophia Entringer, Anh Lian, Meryl Biksacky, Renee D. Pitt, Whitney Mortensen · 2020 · Annals of Pharmacotherapy
26. Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity
    Gregory T. Carter, Aaron M. Flanagan, Mitch Earleywine, Donald I. Abrams, Sunil Kumar Aggarwal, Lester Grinspoon · 2011 · American Journal of Hospice and Palliative Medicine®
27. Ligands for cannabinoid receptors, promising anticancer agents
    Marjan Nikan, Seyed Mohammad Nabavi, Azadeh Manayi · 2016 · Life Sciences
28. Safety of Medical Cannabis in Neuropathic Chronic Pain Management
    A. Bennici, C. Mannucci, Fabrizio Calapai, L. Cardia, Ilaria Ammendolia, S. Gangemi, G. Calapai, Daniel Griscti Soler · 2021 · Molecules
29. An Ethical Exploration of Barriers to Research on Controlled Drugs
    Michael H. Andreae, Evelyn Rhodes, Tyler Bourgoise, George M. Carter, Robert S. White, Debbie Indyk, Henry S. Sacks, Rosamond Rhodes · 2016 · The American Journal of Bioethics
30. The Pharmacological History of Cannabis
    Ethan B. Russo · 2014 · Oxford University Press eBooks
31. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats
    Arunachalam Muthuraman, Nirmal Singh · 2011 · Journal of Natural Medicines
32. Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression
    Stanley Sau Ching Wong, Wing Shing Chan, Chi Wai Cheung · 2020 · Journal of Neuroimmune Pharmacology
33. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
    Sarah D. Pennypacker, Katharine Cunnane, Mary Catherine Cash, Edgar Alfonso Romero-Sandoval · 2022 · Frontiers in Pharmacology
34. Establishing an Optimal “Cutoff” Threshold for Diagnostic Lumbar Facet Blocks
    Steven Paul Cohen, Scott A. Strassels, Connie Kurihara, Scott R. Griffith, Brandon Jesse Goff, Kevin Brant Guthmiller, Hieu T Hoang, Benny Morlando, Conner Nguyen · 2012 · Clinical Journal of Pain
35. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis
    Barth L Wilsey, Reena Deutsch, Emil E. Samara, Thomas D. Marcotte, Allan J. Barnes, Marilyn Ann Huestis, Danny Le · 2016 · Journal of Pain Research
36. State marijuana laws and opioid overdose mortality
    Stanford T. Chihuri, Guohua Li · 2019 · Injury Epidemiology
37. Peripheral neuropathic pain
    Douglas Murphy, Denise D. Lester, Fantley Clay Smither, Ellie Balakhanlou · 2020 · Neurorehabilitation
38. Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses
    Douglas Bruce, John P. Brady, Elissa Foster, Mona M Shattell · 2017 · The Journal of Alternative and Complementary Medicine
39. Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
    Marija Darkovska Serafimovska, Tijana Serafimovska, Zorica Arsova‐Sarafinovska, Sasho Stefanoski, Zlatko Keskovski, Trajan Balkanov · 2018 · Journal of Pain Research
40. Tetrahydrocurcumin exerts protective effect on vincristine induced neuropathy: Behavioral, biochemical, neurophysiological and histological evidence
    N. Greeshma, K. G. Prasanth, Bhaskar Balaji · 2015 · Chemico-Biological Interactions
41. Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics.
    Trafton, Jodie A., Sorrell, John T., Holodniy, Mark, Pierson, Heather, Link, Percy, Combs, Ann, Israelski, Dennis · 2012 · The Journal of Behavioral Health Services & Research
42. Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV
    Caitlin Wei‐Ming Watson, Laura M. Campbell, Ni Sun-Suslow, Suzi Hong, Anya Umlauf, Ronald J. Ellis, Jennifer E. Iudicello, Scott Lee Letendre, Thomas D. Marcotte, Robert K. Heaton et al. · 2021 · Journal of the International Neuropsychological Society
43. High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting
    Gregory Slawson, M‐J Milloy, Lynda G. Balneaves, Annick Simo, Silvia A. Guillemi, Robert S. Hogg, Julio S. G. Montaner, Evan Wood, Thomas H Kerr · 2014 · AIDS and Behavior
44. Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis
    Bellnier, Terrance, Brown, Geoffrey W., Ortega, Tulio R. · 2018 · Mental Health Clinician
45. Management of painful neuropathies
    Nanna Brix Finnerup, Søren Hein Sindrup, Troels Staehelin Jensen · 2013 · Handbook of clinical neurology
46. Update of HIV-Associated Sensory Neuropathies
    Angela Aziz-Donnelly, Taylor B. Harrison · 2017 · Current Treatment Options in Neurology
47. THC and gabapentin interactions in a mouse neuropathic pain model
    Nicholas Atwal, Sherelle L. Casey, Vanessa A. Mitchell, Christopher Walter Vaughan · 2018 · Neuropharmacology
48. Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
    Michelle C. Kaku, Aaron I. Vinik, David M. Simpson · 2015 · Current Diabetes Reports
49. Patient Perceptions of the Use of Medical Marijuana in the Treatment of Pain After Musculoskeletal Trauma: A Survey of Patients at 2 Trauma Centers in Massachusetts
    Marilyn M. Heng, Michael F. McTague, Robert C. Lucas, Mitchel B. Harris, Mark S. Vrahas, Michael J. Weaver · 2017 · Journal of Orthopaedic Trauma
50. Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
    Luiza Reali Nazario, Régis Antonioli, Katiúcia Marques Capiotti, Jaime E. C. Hallak, Antônio Waldo Zuardi, José Alexandre S. Crippa, Carla Denise Bonan, Rosane Souza da Silva · 2015 · Pharmacology Biochemistry and Behavior
51. Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.
    Meldon Kahan, Anita Srivastava, Sheryl M. Spithoff, Lisa A. Bromley · 2014 · Europe PMC (PubMed Central)
52. La Evidencia para el Tratamiento Farmacológico del Dolor Neuropático
    Nanna Brix Finnerup, Søren Hein Sindrup, Troels Staehelin Jensen · 2011 · NeuroTarget
53. Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis
    Jehad Ahmad Barakji, Steven Kwasi Korang, Joshua Buron Feinberg, Mathias Maagaard, Ole Mathiesen, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2023 · PLoS ONE
54. Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
    Birgit Kraft · 2012 · Pharmacology
55. Medical cannabis for chronic pain: can it make a difference in pain management?
    Mari Kannan Maharajan, Yu Jing Yong, Hong Yang Yip, Sze Shee Woon, Kar Mon Yeap, Khai Yeng Yap, Shuen Chi Yip, Kai Xian Yap · 2019 · Journal of Anesthesia
56. Perspectives on Cannabis as a Substitute for Opioid Analgesics
    Sara P. Khan, Thomas A. Pickens, Daniel J. Berlau · 2019 · Pain Management
57. Cannabidivarin for HIV‐Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial
    Luca Eibach, Simone Scheffel, Madeleine Cardebring, Marie Lettau, Melih Ö. Celik, Andreas J. Morguet, Robert Roehle, Christoph Stein · 2020 · Clinical Pharmacology & Therapeutics
58. Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part Two of Two
    Peter J. Cohen · 2009 · Journal of Pain & Palliative Care Pharmacotherapy
59. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy
    Farinaz Nasirinezhad, Stanislava Jergová, James P. Pearson, Jacqueline Sagen · 2014 · Neuropharmacology
60. The challenge of pain evaluation in haemophilia: can pain evaluation and quantification be improved by using pain instruments from other clinical situations?
    Thomas J. Humphries, Craig M. Kessler · 2012 · Haemophilia
61. Medical marijuana in neurology
    Selim R. Benbadis, Juan Sanchez‐Ramos, Ali M. Bozorg, Melissa Giarratano, Kavita Kalidas, Lara W. Katzin, Derrick S. Robertson, Tuan Vu, Amanda Smith, Theresa A. Zesiewicz · 2014 · Expert Review of Neurotherapeutics
62. Can Marijuana Reduce Social Pain?
    Timothy Deckman, C. DeWall, Baldwin M. Way, Rich Gilman, Stephanie B. Richman · 2014 · Social Psychological and Personality Science
63. The Risks and Benefits of Cannabis in the Dermatology Clinic
    Gurbir Dhadwal, Mark G. Kirchhof · 2017 · Journal of Cutaneous Medicine and Surgery
64. Understanding the Etiology and Management of HIV-Associated Peripheral Neuropathy
    Kara Stavros, David M. Simpson · 2014 · Current HIV/AIDS Reports
65. Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection
    Emily W. Paolillo, Lisa C. Obermeit, Bin Tang, Colin A. Depp, Florin Vaida, David J. Moore, Raeanne C. Moore · 2017 · Addictive Behaviors
66. Neuroprotective effect of Azadirachta indica standardized extract in partial sciatic nerve injury in rats: evidence from anti-inflammatory, antioxidant and anti-apoptotic studies
    Amit Dattatraya Kandhare, Anwesha A. Mukherjee-Kandhare, Subhash L. Bodhankar · 2017 · EXCLI journal
67. Overlaps in pharmacology for the treatment of chronic pain and mental health disorders
    Ainsley M. Sutherland, Judith Nicholls, James Bao, Hance A. Clarke · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
68. Use of Cannabinoids for Spasticity and Pain Management in MS
    Hardeep Chohan, Ariele L. Greenfield, Vijayshree Yadav, Jennifer S. Graves · 2015 · Current Treatment Options in Neurology
69. Cannabis for Pain and Headaches: Primer
    Philip S. Kim, Michael Alan Fishman · 2017 · Current Pain and Headache Reports
70. Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain
    Neha Munawar, Mabayoje Ayotunde Oriowo, Willias Masocha · 2017 · Frontiers in Pharmacology
71. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
    Michelle Sexton, José M. Garcia, Aminah Jatoi, Carey S. Clark, Mark S. Wallace · 2021 · JNCI Monographs
72. The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy
    Melvyn Weibin Zhang, Roger Ho · 2015 · Journal of Addiction
73. Treatment Considerations in Painful HIV-Related Neuropathy
    Howard S. Smith · 2011 · Pain Physician
74. Sensory neuropathy and nociception in rodent models of Parkinson's disease
    Lucie Valek, Georg W. J. Auburger, Irmgard Tegeder · 2019 · Disease Models & Mechanisms
75. Investigating the ameliorative effect of alpha‐mangostin on development and existing pain in a rat model of neuropathic pain
    Mahboobeh Ghasemzadeh Rahbardar, Bibi Marjan Razavi, Hossein Hosseinzadeh · 2020 · Phytotherapy Research
76. People living with HIV and the emerging field of chronic pain—what is known about epidemiology, etiology, and management
    Deepika E. Slawek · 2021 · Current HIV/AIDS Reports
77. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
    Tapan Behl, Gagandeep Kaur, SIMONA GABRIELA BUNGAU, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gökhan Zengin, Roxana Daniela Brata, Syed Shams ul Hassan, Ovidiu Frățilă · 2020 · International Journal of Molecular Sciences
78. Cannabinoids for Neuropathic Pain
    Perry G. Fine, Mark J. Rosenfeld · 2014 · Current Pain and Headache Reports
79. Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
    Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda R Chumki, Zvi G. Loewy · 2016 · Parkinson s Disease
80. Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence
    Raúl González, Randi Melissa Schuster, Jasmin Vassileva, Eileen M Martin · 2011 · Journal of Clinical and Experimental Neuropsychology
81. Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice
    Dun Linglu, Yuxiang Li, Ya‐Qiong Xu, Zhou Ru, Lin Ma, Jin Shaoju, Juan Du, Tao Sun, Jianqiang Yu · 2013 · Neurological Sciences
82. Neurologic Complications in Treated HIV-1 Infection
    Nisha S. Bhatia, Felicia C. Chow · 2016 · Current Neurology and Neuroscience Reports
83. Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
    Denise Christina Vidot, Brenda Lerner, Raúl González · 2017 · AIDS and Behavior
84. Priority Considerations for Medicinal Cannabis-Related Research
    Marcel O. Bonn‐Miller, Charles V. Pollack, David Casarett, Richard C. Dart, Mahmoud A. ElSohly, Larry I. Good, Manuel Guzmán, Lumír Hanuš, Kevin P. Hill, Marilyn A. Huestis et al. · 2019 · Cannabis and Cannabinoid Research
85. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy
    Lawrence M. Carey, Zhili Xu, Gabriela Rajic, Alexandros Makriyannis, Julián Romero, Cecilia J. Hillard, Ken Mackie, Andrea G. Hohmann · 2022 · Pharmacological Research
86. CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
    Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, Zhu Zhou · 2024 · Pharmaceutics
87. Medical uses of marijuana (Cannabis sativa): fact or fallacy?
    M. Wj · 2015 · British Journal of Biomedical Science
88. The Achilles Heel of Medical Cannabis Research—Inadequate Blinding of Placebo-Controlled Trials
    David Casarett · 2017 · JAMA Internal Medicine
89. The role of cannabinoids in pain control: the good, the bad, and the ugly
    Joseph V. Pergolizzi, Jo Ann LeQuang, Robert Taylor, Robert B. Raffa, Daniel R. Colucci · 2018 · Minerva Anestesiologica
90. Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms
    David Casarett, Jessica Beliveau, Michelle S. Arbus · 2019 · Journal of Palliative Medicine
91. Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
    Brooks W. Johnson, Natalie H. Strand, John Raynak, Christian Jara, Kisanet Habtegiorgis, Brennan A. Hand, Sang Hong, Jillian A. Maloney · 2025 · Biomedicines
92. Medicinal Cannabis in Orthopaedic Practice
    Lindsay T. Kleeman-Forsthuber, Douglas A. Dennis, Jason M. Jennings · 2019 · Journal of the American Academy of Orthopaedic Surgeons
93. HIV-Related Neuropathy: Pathophysiology, Treatment and Challenges
    Noushin Jazebi, Chad Evans, Hima S. Kadaru, Divya Kompella, Felix Y. Fang, Mukaila A. Raji, Miguel A. Pappolla, Shao-Jun Tang, Jin Mo Chung, Bruce D. Hammock et al. · 2021 · Journal of Neurology and Experimental Neuroscience
94. The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida
    Zachary L. Mannes, Larry E. Burrell, Erin G. Ferguson, Zhi Heng Zhou, Huiyin Lu, Charurut Somboonwit, Robert L. Cook, Nicole Ennis · 2018 · Patient Preference and Adherence
95. Promising treatments for neuropathic pain
    Pedro Schestatsky, Liliane Pinto Vidor, Pablo Brea Winckler, Tatiane Gomes de Araújo, Wolnei Caumo · 2014 · Arquivos de Neuro-Psiquiatria
96. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes
    Arya Shah, Julia R. Craner, Julie L. Cunningham · 2017 · Journal of Substance Abuse Treatment
97. Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
    Stacy D. D’Andre, Sean D. McAllister, Jasdeepa Nagi, Karthik V. Giridhar, Eduardo Ruiz-Macias, Charles L. Loprinzi · 2021 · Integrative Cancer Therapies
98. Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids
    Barth L Wilsey, Reena Deutsch, Thomas D. Marcotte · 2016 · Cannabis and Cannabinoid Research
99. Integrative neuromuscular medicine: Neuropathy and neuropathic pain: Consider the alternatives
    Julie Rowin · 2019 · Muscle & Nerve
100. Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV-Associated Polyneuropathies
     Taylor B. Harrison, Sachiko Miyahara, Anthony J. Lee, Scott R. Evans, Barbara Bastow, David M. Simpson, Ian Gilron, Robert H. Dworkin, Eric S. Daar, Linda Wieclaw et al. · 2013 · Pain Medicine